S-LAM in men: Is pulmonary function different from that seen in women? [2]

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 3, 2008, Pages 356-

  Burger, Charles D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

HORMONAL THERAPY; HUMAN; LETTER; LUNG FUNCTION; LYMPHANGIOLEIOMYOMATOSIS; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT RESPONSE;

EID: 38849192310     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.177.3.356a     Document Type: Letter

References (5)

1. Schiavina M, Di Scioscio V, Contini P, Cavazza A, Fabiani A, Barberis M, Bini A, Altimari A, Cooke RMT, Grigioni WF, et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 2007;176:96-98.
2. Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, Finlay GA, Olson EJ, Ruoss SJ, Maurer JR, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006;173:105-111.
3. Burger CD, Hyatt RF, Staats BA. Pulmonary mechanics in lymphangioleiomyomatosis. Am Rev Respir Dis 1991;143:1030-1033.
4. Yen KT, Putzke JD, Staats BA, Burger CD. The prevalence of acute response to bronchodilator in pulmonary lymphangioleiomyomatosis. Respirology 2005;10:643-648.
5. Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, Cordier JF; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Medicine (Baltimore) 1999;78:321-337.